Large cohort study confirms link between pioglitazone, bladder cancer
Pioglitazone was linked to a 63% increase in bladder cancer risk, compared with other noninsulin antidiabetic drugs in a large population-based cohort study.
Furthermore, incidence rose the longer...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news